Article
Efficacy of TACE Combined with Lenvatinib Plus Sintilimab for Hepatocellular Carcinoma…
Journal of Hepatocellular Carcinoma · 2023 · Ning S, Li X, Ma X, Liu J, Chang X
Key facts
| Title | Efficacy of TACE Combined with Lenvatinib Plus Sintilimab for Hepatocellular Carcinoma with Tumor Thrombus in the Inferior Vena Cava and/or Right Atrium |
|---|---|
| First author | Ning S, Li X, Ma X, Liu J, Chang X |
| Journal | Journal of Hepatocellular Carcinoma |
| Published | Sep 13, 2023 |
| DOI | 10.2147/JHC.S410967 |
| Devices mentioned | 211545 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1